Startup Funding News Today, August 28, 2026: AusperBio, CivilGrid, Transfyr, Yardstik & More

Startup funding over the latest overnight cycle points to a market increasingly willing to finance hard deployment problems rather than broad technology promises. The biggest verified round is AusperBio’s $120 million Series C for hepatitis B therapeutics, followed by Yardstik’s $30 million financing for workforce fraud monitoring and CivilGrid’s $26 million Series A for critical-infrastructure mapping. Together, those three rounds account for the overwhelming majority of disclosed capital among today’s selected deals.

The sector mix is unusually physical. Dental robotics, semiconductor manufacturing, underground utility infrastructure, healthcare and mobility all appear in the latest funding flow. Even the software-heavy deals are attached to operational systems where bad data or failed execution carries real financial consequences.

The Macro Environment: Capital Follows Technical and Operational Moats

Today’s funding does not resemble the indiscriminate software market of the zero-rate era. Investors are writing meaningful checks where startups can point to clinical programs, regulated workflows, proprietary infrastructure data, manufacturing know-how or hardware integration.

AusperBio is the clearest example. The company is already preparing its lead hepatitis B therapy, AHB-137, for a Phase 3 registrational program and potential commercialization. Its $120 million Series C brings capital raised since 2024 to $360 million. That is financing tied to clinical execution rather than an abstract platform thesis.

CivilGrid shows the same pattern in infrastructure software. Its platform consolidates underground utility, property, environmental and regulatory information into a shared planning environment. Spark Capital led the $26 million Series A, while Energy Impact Partners participated alongside early-stage investors. An infrastructure-focused strategic investor matters because CivilGrid sells to utilities and engineering organizations, where industry distribution and credibility can matter as much as software quality.

Yardstik sits inside another high-consequence workflow: workforce screening and fraud detection. The company says revenue grew 149% year over year and is using its $30 million round to extend screening beyond the moment an employee is hired into continuous monitoring of credentials, fraud signals and other risk indicators.

AusperBio raises $120M to move hepatitis B therapies toward commercialization

AusperBio Therapeutics closed a $120 million Series C led by an undisclosed strategic investor, with RA Capital joining as a new investor and existing backers including HanKang Capital, Sherpa Capital, InnoPinnacle Fund, Qiming Venture Partners, YuanBio Venture Capital and CDH Investments participating.

The financing brings total capital raised since 2024 to $360 million. AusperBio plans to use the money primarily to advance AHB-137 through its Phase 3 registrational program and prepare for potential commercialization.

The company is also developing AHB-171, an siRNA therapy targeting hepatitis B. For investors, the significance is straightforward: this is late-stage biotechnology capital moving behind a program approaching a major clinical and regulatory test.

Funding Details

Startup: AusperBio Therapeutics
Investors: Strategic lead investor, RA Capital, HanKang Capital, Sherpa Capital, InnoPinnacle Fund, Qiming Venture Partners, YuanBio Venture Capital, CDH Investments
Amount Raised: $120 million
Total Raised: $360 million since 2024
Funding Stage: Series C
Funding Date: August 27, 2026
Headquarters: San Francisco, California / China operations
Sector: Biotechnology
Valuation: Not disclosed

Yardstik raises $30M in funding to move background screening beyond the hiring date

Minneapolis-based Yardstik raised $30 million in funding led by Harbert Growth Partners, bringing total funding to $65 million. Existing investors Rally Ventures, MissionOG, Crosslink Capital, Grotech Ventures and Great North Ventures also participated.

Yardstik is building what it calls a workforce trust platform around screening, identity verification, fraud detection and continuous monitoring. The company plans to add motor-vehicle reports, exclusion monitoring and automated alerts when employee licenses, insurance or certifications lapse.

The interesting investment thesis is that employee risk does not stop once a background check clears. If companies increasingly treat worker verification as continuous infrastructure rather than a one-time HR task, Yardstik moves from selling checks to owning an ongoing compliance workflow.

Funding Details

Startup: Yardstik
Investors: Harbert Growth Partners, Rally Ventures, MissionOG, Crosslink Capital, Grotech Ventures, Great North Ventures
Amount Raised: $30 million
Total Raised: $65 million
Funding Stage: Series B
Funding Date: August 27, 2026
Headquarters: Minneapolis, Minnesota
Sector: Workforce technology/fraud prevention
Valuation: Not disclosed

CivilGrid raises $26M to build a map of America’s underground infrastructure

CivilGrid raised a $26 million Series A led by Spark Capital, with Energy Impact Partners, Afore Capital, A*, Ford Street Ventures and SNR Ventures participating.

Founder Josh Mackanic previously worked at PG&E and built CivilGrid after seeing how incomplete information about buried infrastructure could delay projects and create high unexpected costs. The startup combines utility, subsurface, environmental, regulatory and land information in a single planning system.

That may sound like a narrow software problem until you consider the economics. U.S. infrastructure projects routinely encounter unknown pipes, cables, easements and permitting constraints. CivilGrid’s opportunity is to turn fragmented information into a data layer used before construction begins.

Funding Details

Startup: CivilGrid
Investors: Spark Capital, Energy Impact Partners, Afore Capital, A*, Ford Street Ventures, SNR Ventures
Amount Raised: $26 million
Total Raised: Not disclosed
Funding Stage: Series A
Funding Date: August 27, 2026
Headquarters: San Francisco, California
Sector: Infrastructure software/construction technology
Valuation: Not disclosed

Lupin Dental raises €15M to push robotics deeper into dentistry

France-based Lupin Dental closed a €15 million Series A led by Fynveur, which invested €10 million. Existing shareholders and private investors participated, and Bpifrance provided additional loan financing.

The company is developing next-generation dental robotics. Details of its commercial rollout remain limited publicly, but the financing is notable because medical robotics requires a combination of engineering, clinical workflow integration, regulatory execution and practitioner adoption.

That gives the company higher technical and distribution barriers than a conventional dental-software startup, but it also makes commercialization slower and more capital intensive.

Funding Details

Startup: Lupin Dental
Investors: Fynveur, existing shareholders, private investors; Bpifrance loan support
Amount Raised: €15 million
Total Raised: Not disclosed
Funding Stage: Series A
Funding Date: August 27/28, 2026
Headquarters: Montpellier, France
Sector: Dental robotics / medtech
Valuation: Not disclosed

Bevel raises $6M as fintech investors continue backing narrower financial products

Financial-technology startup Bevel raised $6 million in seed funding, according to current funding databases tracking August 27 financings. The company is among the larger early-stage fintech transactions appearing in the latest overnight deal set.

The financing is much smaller than the late-stage fintech rounds that dominated venture markets several years ago, reflecting a more selective funding environment for financial software.

At seed stage, investors are increasingly looking for specific distribution wedges and measurable customer economics rather than rewarding companies for entering a large financial-services category alone.

Funding Details

Startup: Bevel
Investors: Not fully disclosed in available sources
Amount Raised: $6 million
Total Raised: Not disclosed
Funding Stage: Seed
Funding Date: August 27, 2026
Headquarters: United States
Sector: Fintech
Valuation: Not disclosed

Transfyr launches with $25M seed funding to capture the missing data inside scientific labs

Cambridge, Massachusetts-based Transfyr launched with $25 million in seed funding led by General Catalyst, with participation from Lux Capital, Breakout Ventures, Factory, Neo, SV Angel, MVP Ventures, Underscore VC, Lyda Hill, and several angel investors.

The startup is building what it calls an observability layer for science, using sensors and multimodal AI models to capture laboratory activity that typically never makes it into scientific papers or formal protocols. That includes operator actions, environmental conditions, equipment telemetry, experimental adjustments, and other details that can determine whether scientific work can be reproduced or scaled.

Founded by former Ginkgo Bioworks AI executive Anna Marie Wagner and ARPA-H founding director Renee Wegrzyn, Transfyr is betting that capturing this missing layer of laboratory data can improve reproducibility, technology transfer, and automation while creating richer training data for AI systems and laboratory robots.

Funding Details

Startup: Transfyr
Investors: General Catalyst (lead), Lux Capital, Breakout Ventures, Factory, Neo, SV Angel, MVP Ventures, Underscore VC, Lyda Hill, and angel investors
Amount Raised: $25 million
Total Raised: $25 million
Funding Stage: Seed
Funding Date: August 27, 2026
Headquarters: Cambridge, Massachusetts
Sector: AI / Scientific Infrastructure
Valuation: Not disclosed

Muchuang Integrated Circuit raises Series B funding for semiconductor development

China’s Muchuang Integrated Circuit completed a Series B financing round for an undisclosed amount, according to current semiconductor funding databases.

The round lands amid continued global investment in semiconductor sovereignty and domestic chip supply chains. China in particular has spent years trying to deepen its local semiconductor capabilities as U.S. export controls restrict access to selected advanced technologies.

Because reliable English-language sources have not publicly disclosed the amount or investor syndicate, the financial significance of this round is difficult to quantify. Its sector placement, however, makes it worth watching.

Funding Details

Startup: Muchuang Integrated Circuit
Investors: Not disclosed
Amount Raised: Not disclosed
Total Raised: Not disclosed
Funding Stage: Series B
Funding Date: August 27, 2026
Headquarters: China
Sector: Semiconductors
Valuation: Not disclosed

Milnda raises seed funding for healthcare technology in Japan

Japanese healthcare startup Milnda completed a seed round for an undisclosed amount dated August 28, according to current funding databases.

The lack of disclosed transaction details limits what can responsibly be inferred about investor conviction or valuation. Still, the deal adds to an overnight funding set already unusually weighted toward healthcare.

For investors, that concentration matters more collectively than individually: biotechnology, dental robotics, and healthcare startups are all attracting new early- or growth-stage capital at the same time.

Funding Details

Startup: Milnda
Investors: Not disclosed
Amount Raised: Not disclosed
Total Raised: Not disclosed
Funding Stage: Seed
Funding Date: August 28, 2026
Headquarters: Japan
Sector: Healthcare/life sciences
Valuation: Not disclosed

Nanolope raises €800K in funding to turn buildings into thermal energy storage

Berlin deep-tech startup Nanolope closed an €800,000 pre-seed round to develop high-density thermal-energy-storage materials that can be integrated into buildings and energy systems.

The company’s thesis is that thermal storage does not necessarily need to sit inside conventional tanks or batteries. If building materials themselves can absorb and release thermal energy, structures could become part of the energy-storage system.

It is an early technical bet, but it sits within a larger macro trend: electricity grids and buildings increasingly need ways to shift energy demand over time as renewable generation grows.

Funding Details

Startup: Nanolope
Investors: Not fully disclosed in available reporting
Amount Raised: €800,000
Total Raised: Not disclosed
Funding Stage: Pre-seed
Funding Date: August 28, 2026
Headquarters: Berlin, Germany
Sector: Climate tech / thermal energy storage
Valuation: Not disclosed

Vumi raises €100K in seed funding to accelerate expansion

Spain-based Vumi raised €100,000 in seed funding to accelerate its commercial expansion and strengthen operations. At this size, the round is better viewed as early validation capital than as a broader institutional market signal. Vumi operates in financial services, a sector where investors have become far more selective following the fintech boom earlier in the decade.

For a seed round of this size, the more meaningful milestone is whether the capital translates into measurable customer adoption and commercial traction, rather than how quickly the company returns to the market for another raise.

Founded in 2022, Vumi operates a SaaS wealth management platform that enables high-net-worth families, family offices, corporations, and private banks to consolidate and monitor their entire wealth portfolio, including financial, alternative, and real estate assets, in one place. Its key differentiator is native banking connectivity with Spanish financial institutions.

Funding Details

Startup: Vumi
Investors: Not disclosed
Amount Raised: €100,000
Total Raised: Not disclosed
Funding Stage: Seed
Funding Date: August 27, 2026
Headquarters: Spain
Sector: Financial services/fintech
Valuation: Not disclosed

What Today’s Funding Activity Reveals

The largest signal is healthcare’s share of serious capital. AusperBio alone raised $120 million, while Lupin Dental adds robotics to the medical-technology mix and Milnda adds another early-stage healthcare company.

Second, infrastructure is attracting capital from investors that understand the industries being disrupted. CivilGrid counts Energy Impact Partners among its backers. That type of strategic participation matters in utilities and construction because customer access can be harder to acquire than technical talent.

Third, the semiconductor and critical-infrastructure themes remain connected to geopolitics. Muchuang represents continued Chinese capital formation around domestic semiconductor capacity, while CivilGrid addresses the physical infrastructure required for U.S. utilities and large construction projects.

Finally, today illustrates how misleading raw funding totals can be. One $120 million biotechnology round dominates the numbers. Beneath it is a much more conservative market of $30 million, $26 million, €15 million, and mostly seed-stage checks. Venture capital is active, but unevenly distributed.

Comparative Funding Table

Strategic Takeaways for Founders and Investors

Technical depth is attracting capital again. AusperBio, Lupin Dental, Muchuang and Nanolope are all working in areas where a competitor cannot reproduce the product by assembling a few APIs.

Workflow ownership remains valuable. Yardstik and CivilGrid both sit inside operational processes where customers already spend significant amounts of money managing risk. That gives them a clearer path to demonstrating financial return.

Strategic investors can shorten distribution cycles. Energy-sector investors backing infrastructure software or industry participants backing healthcare and semiconductor startups can provide access that ordinary venture capital cannot.

Capital concentration remains extreme. The headline funding number looks healthy largely because of AusperBio. Founders should not interpret megadeals as evidence that fundraising has become easy across the market.

Physical systems are becoming software markets. Utilities, dental practices, semiconductor design and building energy management are all examples of industries where software increasingly controls expensive real-world assets.

Conclusion

August 28’s funding activity is less about another wave of generic AI startups and more about investors financing hard-to-replicate operating systems for the physical and regulated economy.

The largest check is going toward a Phase 3 biotechnology program. The next tier backs workforce risk, underground infrastructure and medical robotics. Semiconductor and energy-storage startups fill out the smaller end of the market.

The common denominator is defensibility.

Capital is still available, but investors increasingly want startups attached to something difficult: clinical data, physical infrastructure, regulated workflows, semiconductor know-how or technology that has to work outside a browser.